Department: DEPARTMENT OF HEALTH AND HUMAN SERVICES
Years: 20002001200220032004200520062007200820092010201120122013[FR Doc 00-55519] 26. Drugs for Human Use
CFR Correction
In Title 21 of the Code of Federal Regulations, parts 300 to 499, revised as of April 1, 2000, make the following corrections:
1. On page 56, Sec. 310.545 is corrected by adding paragraph (d)(2) to read as follows:
Sec. 310.545 Drug products containing certain active ingredients
offered overthecounter (OTC) for certain uses.
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-32994] 27. Medicare and Medicaid Programs
This document corrects a technical error that appeared in the November 30, 2000 Regulatory Plan and the November 30, 2000 Unified Agenda. The Regulatory Plan included HHSHCFA sequence number 57 Physicians' Referrals to Health Care Entities With Which They Have Financial RelationshipsPhase II (HCFA1810FC) that concerns the physician referral
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health Care Financing Administration
[FR Doc 00-55520] 28. Protection of Human Subjects
CFR Correction
In Title 21 of the Code of Federal Regulations, parts 1 to 99,
revised as of April 1, 2000, on page 278, Sec. 50.3 is corrected by removing and reserving paragraph (b)(11).
[FR Doc. 0055520 Filed 122600; 8:45 am]
BILLING CODE 150501D
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-32702] 29. Child Support Enforcement Program; Incentive Payments, Audit Penalties
This final rule implements the statutory requirement of the Social Security Act that requires the Secretary of Health and Human Services to establish the new performancebased incentive system. It also implements a performancebased penalty system and establishes standards for certain types of audits. Finally, this rule includes a requirement that
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Western Area Power Administration
[FR Doc 00-33087] 30. Cooperative Agreement to Support the Shellfish and Seafood Safety Assistance
The Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), Office of Seafood (OS) is announcing its intent to award, noncompetitively, a cooperative agreement to the Interstate Shellfish Sanitation Conference (ISSC) in the amount of $275,000 for the first year. Subject to the availability of Federal funds and
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-31611] 31. National Medical Support Notice
This rule implements provisions of the Child Support Performance and Incentives Act of 1998 (CSPIA), Public Law 105200, that require State child support enforcement agencies, under title IVD of the Social Security Act (the Act), to enforce the health care coverage provision in a child support order through the use of the National Medical Support
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Western Area Power Administration
[FR Doc 00-33020] 32. Anti-Infective Drugs Advisory Committee; Notice of Meeting
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: AntiInfective Drugs Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-32889] 33. Antiviral Drugs Advisory Committee; Notice of Meeting
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Antiviral Drugs Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.
Date
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-32890] 34. Antiviral Drugs Advisory Committee; Notice of Meeting
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Antiviral Drugs Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.
Date
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-32891] 35. Arthritis Advisory Committee; Notice of Meeting
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Arthritis Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.
Date and
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-33022] 36. Advisory Committee on Special Studies Relating to the Possible Long-Term
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Advisory Committee on Special Studies Relating
to the Possible LongTerm Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hand Advisory Committee).
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-33021] 37. Transmissible Spongiform Encephalopathies (TSE) Advisory Committee; Notice of
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public.
Name of Committee: Transmissible Spongiform Encephalopathies (TSE) Advisory Committee.
General Function of the Committee: To provide advice and
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-33019] 38. Vaccines and Related Biological Products Advisory Committee; Notice of
This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.
Name of Committee: Vaccines and Related Biological Products Advisory Committee.
General Function of the Committee: To provide advice and recommendations to the agency on FDA's
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 00-32925] 39. Center for Substance Abuse Treatment; Notice of Meeting
Pursuant to Pub. L. 92463, notice is hereby given of a meeting of the Center for Substance Abuse Treatment (CSAT) National Advisory Council to be held in January 2001. A portion of the meeting will be open and include discussion of the Center's policy issues and current administrative, legislative, and program developments. The Council will
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Substance Abuse and Mental Health Services Administration
[FR Doc 00-32932] 40. Hanford Health Projects Inter-Tribal Council et al.; Notice of Meeting
Public meeting of the Intertribal Council on Hanford Health Projects (ICHHP) in association with the Citizens Advisory Committee on Public Health Service (PHS) Activities and Research at Department of Energy (DOE) Sites: Hanford Health Effects Subcommittee.
Name: Public meeting of the Intertribal Council on Hanford Health Projects (ICHHP)
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Agency for Toxic Substances and Disease Registry
[FR Doc 00-32993] 41. Medicare Program; Prospective Payment System for Inpatient Rehabilitation
This notice extends the comment period on a proposed rule published in the Federal Register on November 3, 2000 (65 FR 66304). That rule would implement section 1886(j) of the Social Security Act (the Act), as added by section 4421 of the Balanced Budget Act of 1997 (Public Law 10533) and as amended by section 125 of the Balanced Budget Refinement
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health Care Financing Administration
[FR Doc 00-32931] 42. Citizens Advisory Committee on Public Health Service (PHS) Activities and
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Agency for Toxic Substances and Disease Registry (ATSDR) and the Centers for Disease Control and Prevention (CDC) announce the following meeting.
Name: Citizens Advisory Committee on PHS Activities and Research at DOE Sites: Hanford Health Effects
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Agency for Toxic Substances and Disease Registry
[FR Doc 00-32995] 43. Medicare Program; Requirements for the Recredentialing of Medicare+Choice
This proposed rule would change the requirement of recredentialing providers, who are physicians or other health care professionals, for Medicare+Choice Organizations (M+COs) from at least every 2 years to at least every 3 years. This change is consistent with managed care industry recognized standards of practice and quality, and with standards
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health Care Financing Administration
[FR Doc 00-32933] 44. Citizens Advisory Committee on Public Health Service (PHS) Activities and
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92463), the Agency for Toxic Substances and Disease Registry (ATSDR) and the Centers for Disease Control and Prevention (CDC) announce the following meeting.
Name: Citizens Advisory Committee on PHS Activities and Research at DOE Sites: Oak Ridge Reservation
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Agency for Toxic Substances and Disease Registry
[FR Doc 00-32922] 45. Notice of Hearing: Reconsideration of Disapproval of Rhode Island State Plan
This notice announces an administrative hearing on January 25, 2001; 10:00 a.m.; Twentysecond Floor; Room 2255; JFK Federal Building; Boston, Massachusetts 022030003, to reconsider our decision to disapprove Rhode Island (SPA) 00003.
Published: 2000-12-27 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health Care Financing Administration
[FR Doc 00-32817] 46. Submission for OMB review; comment request; Evaluation of a Public Education
Under the provisions of Section 3507(a)(2)(A) of the Paperwork Reduction Act of 1995, the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed
Published: 2000-12-26 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 00-32814] 47. Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by agencies of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage
Published: 2000-12-26 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 00-32815] 48. Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by agencies of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage
Published: 2000-12-26 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 00-32816] 49. Prospective Grant of Exclusive License: Hydroxylamine Compositions for the
This notice, in accordance with 35 U.S.C. 209(c))1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, in contemplating the grant of an exclusive license worldwide to practice the invention embodied in: U.S. Patent Number 6,001,853 issued December 14, 1999 entitled, ``Hydroxylamine
Published: 2000-12-26 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
[FR Doc 00-32783] 50. Agency Information Collection Activities; Submission for OMB Review; Comment
The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Published: 2000-12-26 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
Years: 20002001200220032004200520062007200820092010201120122013